Town Health International Medical Gp : Announcements and Notices -

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

Town Health International Medical Group Limited ੰ਄਷ყᔼᐕණྠϞࠢʮ̡

(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)

(Stock Code: 3886)

SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING

Reference is made to the notice of annual general meeting of Town Health International Medical Group Limited ("Company") dated 29 May 2018 ("Original Notice"), by which the Company convenes an annual general meeting to be held at 9:00 a.m. on Friday, 29 June 2018 at 1st Floor, Town Health Technology Centre, 10-12 Yuen Shun Circuit, Siu Lek Yuen, Shatin, New Territories, Hong Kong ("Meeting") and this supplemental notice shall be read together with the Original Notice.

SUPPLEMENTAL NOTICE IS HEREBY GIVEN that in addition to the resolutions set out in the Original Notice, the following resolutions will be considered and, if thought fit, approved by shareholders of the Company at the Meeting:

ORDINARY RESOLUTIONS

• 8. "THAT Mr. Yu Kai Fung Jackie be appointed as a director of the Company."

• 9. "THAT Mr. Wong Sai Kit be appointed as a director of the Company."

By order of the Board

Town Health International Medical Group Limited

Lee Chik Yuet

Executive Director

Hong Kong, 14 June 2018

Registered office:	Head office and principal place of
Canon's Court	business in Hong Kong:
22 Victoria Street	6th Floor
Hamilton HM 12	Town Health Technology Centre
Bermuda	10-12 Yuen Shun Circuit
Siu Lek Yuen
Shatin, New Territories
Hong Kong
Notes:

• 1. A shareholder of the Company ("Shareholder") entitled to attend and vote at the meeting convened by the above notice is entitled to appoint one or more proxy to attend and, subject to the provisions of the bye-laws of the Company, to vote on his/her/its behalf. A proxy need not be a Shareholder but must be present in person at the Meeting to represent the Shareholder. If more than one proxy is so appointed, the appointment shall specify the number and class of shares in respect of which each such proxy is so appointed.

• 2. To ascertain the entitlement of the Shareholders to attend and vote at the Meeting, the register of members of the Company will be closed from Tuesday, 26 June 2018 to Friday, 29 June 2018, both days inclusive, during which no transfer of shares of the Company ("Shares") will be effected. In order to qualify for the entitlement to attend and vote at the Meeting, all transfers of Shares accompanied by the relevant share certificates must be lodged with the Company's branch share registrar and transfer office in Hong Kong, Tricor Tengis Limited at Level 22, Hopewell Centre, 183

• Queen's Road East, Hong Kong, by 4:30 p.m. on Monday, 25 June 2018.

• 3. Since the original form of proxy which was despatched by the Company to the Shareholders on 29 May 2018 ("Original Form of Proxy") and sent together with the Original Notice does not contain the proposed resolutions set out in this supplemental notice, a revised form of proxy ("Revised Form of Proxy") has been prepared and is enclosed with the supplemental circular of the Company dated 14 June 2018 ("Supplemental Circular") of which this supplemental notice forms part.

• 4. To be valid, the Revised Form of Proxy, together with the power of attorney or other authority (if any) under which it is signed (or a notarially certified copy thereof), must be deposited at the office of the Company's branch share registrar and transfer office in Hong Kong, Tricor Tengis Limited at Level 22, Hopewell Centre, 183 Queen's Road East, Hong Kong, by 9:00 a.m. on Wednesday, 27 June 2018 or not less than 48 hours before the time appointed for holding the adjourned Meeting ("Closing

  Time").

• 5. Completion and return of an instrument appointing a proxy will not preclude a Shareholder from attending and voting in person at the Meeting or any adjournment thereof and in such event the instrument appointing a proxy shall be deemed to be revoked.

• 6. If a Shareholder has not yet returned the Original Form of Proxy in accordance with the instructions printed thereon, and wishes to appoint a proxy to attend the Meeting on his/her/its behalf, he/she/it is required to submit the Revised Form of Proxy. In this case, the Shareholder shall not submit the Original Form of Proxy.

• 7. If a Shareholder has already returned the Original Form of Proxy in accordance with the instructions printed thereon, he/she/it should note that:

  (i) If no Revised Form of Proxy is returned by the Shareholder, the Original Form of Proxy will be treated as a valid form of proxy lodged by the Shareholder if duly completed. The proxy appointed under the Original Form of Proxy will also be entitled to vote in accordance with the instructions previously given by the Shareholder or at his/her discretion (if no such instructions are given) on any resolution properly put to the Meeting (including the additional proposed resolutions as set out in the Supplemental Circular and this supplemental notice).

  • (ii) If the Revised Form of Proxy is returned by the Shareholder at or before the Closing Time in accordance with the instructions printed thereon, the Revised Form of Proxy will be treated as a valid form of proxy lodged by the Shareholder if duly completed, and will revoke and supersede the Original Form of Proxy previously lodged by him/her/it.

  • (iii) If the Revised Form of Proxy is returned by the Shareholder after the Closing Time, the Revised Form of Proxy will be deemed invalid. It will not revoke the Original Form of Proxy previously lodged by the Shareholder. The Original Form of Proxy will be treated as a valid form of proxy lodged by the Shareholder if duly completed. The proxy appointed under the Original Form of Proxy will also be entitled to vote in accordance with the instructions previously given by the Shareholder or at his/her discretion (if no such instructions are given) on any resolution properly put to the Meeting (including the additional proposed resolutions as set out in the Supplemental Circular and this supplemental notice).

• 8. As required under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, all the above resolutions will be decided by way of poll.

• 9. References to time and dates in this supplemental notice are to Hong Kong time and dates.

As at the date of this notice, the executive Directors are Miss Choi Ka Yee, Crystal (Chairperson), Dr. Hui Ka Wah, Ronnie, JP (Chief Executive Officer), Mr. Lee Chik Yuet and Mr. Wong Seung Ming (Chief Financial Officer); the non-executive Directors are Dr. Choi Chee Ming, GBS, JP (Deputy Chairman), Ms. Fang Haiyan (Deputy Chairperson), Mr. Tsai Ming-hsing (Deputy Chairman), Mr. Chen Jinhao and Dr. Cho Kwai Chee; and the independent non-executive Directors are Mr. Ho Kwok Wah, George, MH, Mr. Wong Tat Tung, MH, JP, Mr. Yu Xuezhong, Ms. Li Mingqin and Mr. Wang John Hong-chiun.